WebDec 6, 2014 · DLBCL subtype (GCB vs non-GCB) was determined by a central pathology lab using immunohistochemistry (IHC) per the Hans method (Hans 2004). Pts were stratified by subtype, then randomized 1:1 to receive Len (25 mg/day, 21 days of 28-day cycle) or IC (gemcitabine, rituximab, etoposide, or oxaliplatin) until progressive disease (PD), … WebMay 25, 2024 · For GCB and non-GCB/ABC patients data was collected including demographics, stage, initial and subsequent chemo, response and SCT. Results: Out of …
VEGF检测在T-CHOP治疗初治GCB与非GCB型DLBCL中的预后价值_ …
Web目前,对于gcb和non-gcb亚型de-dlbcl患者预后差异的研究结果尚存在差异。有文献报道,gcb或non-gcb亚型de-dlbcl患者的预后均较非de-dlbcl显著变差(p<0.05) [19,20] 。 WebNon-GCB versus GCB resulted in less DEP in relation to DLBCL versus HD comparison (Figure 5a,b). Given that platelets are considered a major contaminant in EV preparations, potential contaminant proteins from erythrocytes, platelets and the blood coagulation system extracted from Geyer et al. [ 23 ] are highlighted in red, orange and blue in ... refurbished tonal gym
CD10, BCL6, and MUM1 expression in diffuse large B‐cell …
WebNov 27, 2014 · Those patients with non-GCB DLBCL treated with R-CHOP were found to have worse progression-free survival (HR = 3.21; 95% CI, 1.29-8.00) and overall survival … WebThe prognostic significances of the germinal center B-cell-like (GCB) and non-germinal center B-cell-like (non-GCB) types of diffuse large B-cell lymphoma (DLBCL) have been … WebGene expression profiling has revealed that diffuse large B-cell lymphoma ( DLBCL) is composed of at least 3 different sub-groups, each having distinct oncogenic mechanisms … refurbished tomtom go 510